__________________________________________________________________________________________
Re: Local ID TH140602113 / TH201406005920 FU (1)
Thank you for reporting to us an adverse event related to Lilly product.
We would like to collect more information to better understanding the reported event.
Please respond to following questions regarding the adverse event – barely eat, rigid tongue and difficulty keeping eyes open, involving a female patient, 93 Yrs who was subscribed Forteo, reported the event to Lilly on 16/JUN/2014.
Please, contact the initial reporter and ask the following questions:
1. Relevant medical history
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
2. Onset date and stop date for the events
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
3. Outcome for the events
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
4. Concomitant medication (IFU)
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
5. Laboratory exams (values and units)
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
6. Corrective treatment
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
7. Relatedness opinion for the events
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
Thanks
Yours sincerely,
ELI LILLY AND COMPANY
Sasithorn Suntharo
Pharmacovigilance Associate
HCP’s signature:
Date:
__________________________________________________________________________________
For Eli Lilly internal use only
Date of Confirmation of FU request sent to HCP:
Name and Designation: